Park, Richard <br/><br/>
Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2005 
 - 4601-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-2188  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Area Under Curve<br/>CDC2 Protein Kinase--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HT29 Cells<br/>Humans<br/>Inhibitor of Apoptosis Proteins<br/>Injections, Intravenous<br/>K562 Cells<br/>Masoprocol--administration & dosage<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred ICR<br/>Microtubule-Associated Proteins--genetics<br/>Neoplasm Proteins<br/>Neoplasms, Experimental--genetics<br/>RNA, Messenger--genetics<br/>Survivin<br/>Tissue Distribution<br/>Xenograft Model Antitumor Assays--methods